No press releases found.
Cypherpunk Shareholders Back Board, Pay and Auditor Choices
TipRanks (Mon, 22-Jun 4:57 PM ET)
Cypherpunk Technologies Inc is a privacy technology company focused on implementing a digital asset treasury business anchored by Zcash, which is a cryptographic digital asset that operates on a decentralized, open-source blockchain network known as the Zcash Network. Through its subsidiary, the company is also engaged in developing novel therapies for patients with cancer. The group holds Zcash as part of its digital treasury business and has the following drug candidates under development in its biopharma business: Sirexatamab (DKN-01), a monoclonal antibody that inhibits Dickkopf-related protein 1, or DKK1; and a preclinical antibody program, FL-501, that is designed to treat cachexia-related indications.
Cypherpunk Technologies trades on the NASDAQ stock market under the symbol CYPH.
As of June 26, 2026, CYPH stock price climbed to $0.62 with 1,210,327 million shares trading.
CYPH has a beta of 2.61, meaning it tends to be more sensitive to market movements. CYPH has a correlation of 0.05 to the broad based SPY ETF.
CYPH has a market cap of $65.85 million. This is considered a Micro Cap stock.
The top ETF exchange traded funds that CYPH belongs to (by Net Assets): VTI, VXF, PINK.
CYPH support price is $.53 and resistance is $.67 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CYPH shares will trade within this expected range on the day.